Skip to content
Menu

Leverage Shares 2X Long FIX Daily ETF FIXX

Full chart Compare
Set alert

Price alert · FIXX

All alert types
4.38 USD -0.69 (-13.61%)

As ofNov 20, 2026, 3:58 PM EST

4.25 Day range 4.45
3.87 52-week range 15.67
YTD
-69.05%
1 year
-69.05%

5D -0.81 (-14.57%)

4.5055.50WedThuFriTue4.75
Assets
$272.80K
Expense ratio
0.99%
NAV
4.96
Holdings
4
Asset class
Equity
Issuer
LeverageShares
Inception
Aug 19, 2026
YTD return
-69.05%
1-year return
-69.05%
Volume
9.14K
Avg volume
7.91K
Open
4.57
Previous close
5.07
Day's range
4.25 – 4.45
52-week range
3.87 – 15.67
50-day average
13.80
200-day average
16.10

About Leverage Shares 2X Long FIX Daily ETF

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on FIXX — it syncs with the Stock Master app.